Form 8-K - Current report:
SEC Accession No. 0001171843-13-003896
Filing Date
2013-10-04
Accepted
2013-10-03 18:29:29
Documents
2
Period of Report
2013-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K FILING DOCUMENT document.htm 8-K 13078
2 PRESS RELEASE newsrelease.htm EX-99 5754
  Complete submission text file 0001171843-13-003896.txt   20121
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

EIN.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 131135028
SIC: 8731 Services-Commercial Physical & Biological Research